Risk assessment in a Chinese cohort of 96 318 females undergoing opportunistic cervical cancer screening
Despite the higher risks in our cohort, the ASCCP clinical action threshold remains portable. For women with minimal abnormalities or normal results, shortened follow-up intervals should be considered.
Authors
- Wenhan Li (ORCID: https://orcid.org/0000-0002-9412-1166)
- Liying Wu (ORCID: https://orcid.org/0000-0002-3139-6875)
- Jing Cai (ORCID: https://orcid.org/0000-0002-0302-9998)
- Dingyu Chen
- Weichao Liu (ORCID: https://orcid.org/0009-0003-6802-2740)
- Jing Zhao (ORCID: https://orcid.org/0000-0002-1198-0556)
- Bangxing Huang
- Si Sun (ORCID: https://orcid.org/0000-0002-8424-5763)
- Shi Du
- Pei–Ming Yang (ORCID: https://orcid.org/0000-0003-3473-4611)
- Wuliang Wang (ORCID: https://orcid.org/0000-0002-0061-5043)
- Guoqing Li (ORCID: https://orcid.org/0000-0002-6557-1301)
- Zehua Wang (ORCID: https://orcid.org/0000-0001-6423-8219)
- Liqiong Cai (ORCID: https://orcid.org/0000-0001-6910-4586)
- Zhongya Pan
Institutions
- Second Affiliated Hospital of Zhengzhou University (CN)
- Hubei Provincial Women and Children's Hospital (CN)
- Wuhan Union Hospital (CN)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1093/oncolo/oyaf197
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Natural Science Foundation of China